HWM
UTHR icon

Hemington Wealth Management’s United Therapeutics UTHR Stock Holding History

Hemington Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$45K Buy
109
+8
+8% +$2.69K 0.01% 395
2025
Q2 		$29K Buy
101
+11
+12% +$3.29K ﹤0.01% 494
2025
Q1 		$27K Buy
90
+9
+11% +$3.08K ﹤0.01% 490
2024
Q4 		$28K Buy
81
+17
+27% +$6.25K 0.01% 458
2024
Q3 		$23K Buy
+64
New +$21.6K 0.01% 477

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Hemington Wealth Management's UTHR Position: Q3 2025 in Review

Hemington Wealth Management increased its United Therapeutics (UTHR) stake by 7.9% in Q3 2025, buying an estimated $2.69K and bringing the position to 109 shares worth $45K. The position accounts for 0.01% of the portfolio, ranked #395.

Hemington Wealth Management first reported a position in UTHR in Q3 2024 and has held it in 5 quarters since. 708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Hemington Wealth Management held 109 shares of United Therapeutics worth $45K as of Q3 2025.
  • Hemington Wealth Management bought 8 United Therapeutics shares in Q3 2025, an estimated $2.69K.
  • United Therapeutics made up 0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #395 holding.
  • Hemington Wealth Management first reported a position in United Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.